by admin | Sep 29, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions, Video
A short video about Longevity Summit Dublin 2023 held on August 17-20, 2023 At Longevity Summit Dublin, our mission is to recognise emerging research developments to extend human healthspan by gathering together world leading scientists. The conference...
by admin | Sep 28, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
San Francisco, CA, September 28, 2023 — The Healthspan Action Coalition commemorates International Longevity Day, October 1 and Longevity Month, October, as a day of activism promoting healthy aging through a live rally and walk from San Francisco’s Ferry Building to...
by admin | Sep 28, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By inside Precision Medicine A new method of genome manipulation can rapidly engineer RNA viruses through precise cleavage and repair, with potential applications for antiviral therapeutics, vaccines, and screening of mutations. The new recombinant technology enables...
by admin | Sep 27, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions, Video
by Benjamin Thompson & Shamini Bundell – Nature A stem cell vital for vertebral growth also drives spine metastases, and the use of MDMA in the treatment of PTSD. Cancer cells can spread to bones in the late stages of disease and in many cancers,...
by admin | Sep 26, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By St. Jude Children’s Research Hospital Scientists at St. Jude found that a subset of CD8+ T cells in the brain lessens the activation of microglia and limits disease pathology in a model of Alzheimer’s disease. As many as 5.8 million Americans are currently...
by admin | Sep 25, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Lizzy Lawrence – Stat The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans. The technology is close enough to reality that the Food and Drug Administration has decided to convene a two-day panel...
